Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2009
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009US7615646 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
11/10/2009US7615572 Pyrrole and pyrazole DAAO inhibitors
11/10/2009US7615552 Fused heterocyclic compounds
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/05/2009WO2009134726A1 Substituted pyrimidine derivatives as histamine h4 receptor ligands
11/05/2009WO2009132774A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/05/2009WO2009102377A3 Antibiotic tetrahydro-beta-carboline derivatives
11/05/2009US20090275754 Narcotine Purification Process
11/05/2009US20090275602 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
11/05/2009US20090274733 Pharmaceutical preparation containing copolyvidone
11/05/2009US20090274656 Hepatitis c virus inhibitors
11/05/2009CA2720846A1 Novel inhibitors of hepatitis c virus replication
11/04/2009EP2113503A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/04/2009EP1844045B1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
11/04/2009EP1624874B1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/04/2009EP1617806B1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2009EP1446387B1 Substituted aryl 1,4-pyrazine derivatives
11/04/2009EP0879236B1 Derivatives of camptothecin for use in treating cancer
11/03/2009US7612213 (E)-ethyl 7-hydroxy-2-methyl-2-heptenate; (3E, 5E)-tert-butyl-9-(tert-butyldimethylsiloxy)-2-[(E)-ethylid ene]-4-methylnona-3,5-dienate
11/03/2009US7612206 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612086 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation
11/03/2009US7612081 Such as tert-butylester of 20S-(4-{[3-(7-camptothecinylidene-amino)-propyl]-tert-butoxycarbonyl-amino}-butyl)-(3-tert-butoxycarbonylaminopropyl)-carbamic acid; topoisomerase I inhibiting activity and useful for treatment of tumors and viral and parasite infections
11/03/2009US7612063 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer
11/03/2009US7612054 Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
11/03/2009CA2515507C Imaging system
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/03/2009CA2442423C Therapeutic drug for psychoneurotic disorders
10/2009
10/29/2009WO2009132313A2 Morphinan derivatives of organic and inorganic acids
10/29/2009WO2009131246A1 Sordarin derivatives for preventing or treating infectious diseases caused by pathogenic microorganisms
10/29/2009WO2009097567A4 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
10/29/2009US20090270478 Ion channel modulating activity ii
10/29/2009US20090270467 5-[(1S,3S,4R)-3-Amino-4-(2,4,5-trifluorophenyl)cyclohexyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine, used for treating insulin resistance, hyperglycemia and non-insulin dependent diabetes in mammals
10/29/2009US20090270435 Spiroketone Acetyl-CoA Carboxylase Inhibitors
10/29/2009US20090270372 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/29/2009US20090270371 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders
10/29/2009US20090270368 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
10/29/2009US20090270364 Substituted pyrimidine derivatives
10/29/2009US20090265866 Xanthene Dyes
10/28/2009EP2112154A1 Esters in position 20 of camptothecins
10/28/2009EP2111406A1 Substituted spirochromanone derivatives as acc inhibitors
10/28/2009EP1745052B9 Hiv integrase inhibitors: cyclic pyrimidinone compounds
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009CN101565402A Indeno isoquinolone compound and preparation method and medical application thereof
10/28/2009CN100554270C Method for preparing dehydrogenated cavidine, dehydrogenated apocavidine and combination
10/28/2009CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
10/27/2009US7608740 Method of synthesizing key intermediates for the production of camptothecin derivatives
10/27/2009US7608726 Substituted indolepyridinium as anti-infective compounds
10/27/2009US7608622 1 -Phenylerhyl)-6-(3,4,5-trimethoxyphenyl)- 1 ,3-dihydroimidazo[4,5-b]pyrazin-2-one;
10/27/2009CA2465534C Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/22/2009WO2009128964A2 Ensemble-based virtual screening reveals novel antiviral compounds for avian influenza neuraminidase
10/22/2009WO2009128019A1 Tricyclic antibiotics
10/22/2009WO2009127609A1 Spirocyclic derivatives as histone deacetylase inhibitors
10/22/2009WO2009127218A1 Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
10/22/2009WO2009099625A3 Cyclopamine tartrate salt and uses thereof
10/22/2009US20090264521 Percutaneous absorption preparation
10/22/2009US20090264435 Novel Aryl- and Heteroarylpiperazines
10/22/2009US20090263341 Soft anticholinergic esters
10/22/2009CA2721467A1 Spirocyclic derivatives as histone deacetylase inhibitors
10/22/2009CA2721007A1 Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
10/22/2009CA2720672A1 Tricyclic antibiotics
10/21/2009EP2110377A1 Spirocyclic derivatives as histone deacetylase inhibitors
10/21/2009EP2110141A1 Protective agent for retinal nerve or optic nerve
10/21/2009EP2109615A1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators
10/21/2009EP1846412B1 Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin
10/21/2009EP1346993B1 Lactam compounds and medical use thereof
10/21/2009CN101563324A Spiro-piperidine derivatives
10/21/2009CN101563323A Spiro-piperidine derivatives
10/21/2009CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
10/20/2009US7605169 Antibacterial agents
10/20/2009US7605157 Tricyclic tetrahydroquinoline antibacterial agents
10/20/2009US7605111 Herbicides
10/20/2009CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2009CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/15/2009WO2009126584A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009WO2009125594A1 Optically active dibenzazepine derivatives
10/15/2009WO2009124692A1 New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
10/15/2009WO2009072062A3 Derivatives of dihydroxypyrrolidine as anti- cancer compounds
10/15/2009US20090259043 Tricyclic cytoprotective compounds
10/15/2009US20090259008 Vinyl Monomer And Polymer Derived From The Monomer, And Light Emitting Device Using The Polymer
10/15/2009US20090258890 Topoisomerase-targeting agents
10/15/2009CA2719538A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/14/2009EP2108641A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
10/14/2009EP2108018A2 8-oxa-1,4-diazaspiro [4,5] dec-3-en-1-yl and 1,4,8-triazaspiro [4,5] dec-3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
10/14/2009EP2044076B1 Process for the preparation of asenapine and intermediate products used in said process.
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009CN101558073A Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6h-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof
10/14/2009CN101558066A Pyrrole derivatives with antibacterial activity
10/14/2009CN101555250A Preparation method of topotecan hydrochloride
10/14/2009CN100549010C Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations containing the same
10/14/2009CN100549007C Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
10/14/2009CN100549004C Spirocyclic heterocyclic derivatives and methods of their use
10/14/2009CN100548988C Metabolites of ecteinascidin 743
10/14/2009CN100548980C Isoindoline derivative
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601833 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
10/13/2009US7601736 Pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same
10/13/2009US7601734 Cyclic amine compound
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 298